Showing results (2171-2180 of 3,446) with videos related to

Sort By:
Pageof 345
Cardiovascular Research|March 17, 2004
Transgenic triadin 1 overexpression alters SR Ca2+ handling and leads to a blunted contractile response to beta-adrenergic agonistsUwe Kirchhefer, Larry R Jones, Frank Begrow, et al.
Nature Medicine|July 19, 2005
The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophyMonika Buitrago, Kristina Lorenz, Alexander H Maass, et al.
Human Pathology|December 26, 2006
Lower expression levels of the transforming growth factor beta receptor type II protein are associated with a less aggressive tumor phenotype and improved survival among patients with clear cell renal cell carcinomaAlexander Scott Parker, Christine M Lohse, Kevin Wu, et al.
Gastroenterology|September 9, 2008
Identification of CD4 T-cell epitopes in soluble liver antigen/liver pancreas autoantigen in autoimmune hepatitisHeiko Mix, Christina Weiler-Normann, Robert Thimme, et al.
BJU International|February 4, 2012
Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinomaJacob Jorns, David D Thiel, Christine M Lohse, et al.
World Journal of Surgery|March 14, 2012
Adrenalectomy improves outcomes of selected patients with metastatic carcinomaBianca J Vazquez, Melanie L Richards, Christine M Lohse, et al.
Endocrine|May 1, 2019
Extended cycle streptozotocin/5-FU chemotherapy for maintenance therapy in pancreatic neuroendocrine tumorsJoerg Schrader, Frank O Henes, Michael Blaeker, et al.
International Journal of Dermatology|April 11, 2019
Wide local excision prior to sentinel lymph node biopsy for primary melanoma of the head and neckMatthew M May, Christine M Lohse, Eric J Moore, et al.
The Journal of Urology|October 12, 2005
A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trialsBradley C Leibovich, John C Cheville, Christine M Lohse, et al.
Hepatology Communications|May 8, 2019
Transjugular Intrahepatic Portosystemic Shunt: A Possible Risk Factor for Direct-Acting Antiviral Treatment Failure in Patients With Hepatitis C?Felix Piecha, Jan-Michael Gänßler, Sabine Jordan, et al.
Pageof 345